Risk Factors for Acute and Chronic GVHD
Dr. Gooptu explains the risk factors associated with both acute and chronic GVHD.
Stay updated with breaking news from Agvhd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dr. Gooptu explains the risk factors associated with both acute and chronic GVHD.
Eno-Abasi Inyang, PharmD, BCPS, BCOP provides an overview of the various conditioning regimens employed for allogeneic stem cell transplantation.
Clinical pearls for community oncologists regarding treatment selection and sequencing in chronic GvHD patients.
Addressing patient monitoring in chronic GvHD, including therapy adjustment indicators and frequency.
The FDA has released a complete response letter to its biologics license application resubmission, indicating that it needs more data to support approval for remestemcel-L for the treatment of pediatric patients with steroid-refractory acute graft-vs-host disease.